INT108935

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.59
First Reported 2003
Last Reported 2009
Negated 0
Speculated 0
Reported most in Abstract
Documents 5
Total Number 5
Disease Relevance 0.50
Pain Relevance 4.38

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (Arrb2) cytoplasmic membrane-bounded vesicle (Arrb2) plasma membrane (Arrb2)
nucleus (Arrb2) intracellular (Arrb2) cytoplasm (Arrb2)
Anatomy Link Frequency
brain 2
cerebral cortex 1
hippocampus 1
Arrb2 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Central grey 13 99.84 Very High Very High Very High
Hippocampus 8 99.84 Very High Very High Very High
Morphine 42 99.76 Very High Very High Very High
cerebral cortex 12 98.88 Very High Very High Very High
tolerance 8 94.76 High High
Locus ceruleus 8 88.68 High High
opioid receptor 8 86.64 High High
agonist 4 84.52 Quite High
narcan 4 83.92 Quite High
withdrawal 4 82.16 Quite High
Disease Link Frequency Relevance Heat
Urological Neuroanatomy 13 99.84 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Periaqueductal gray was removed for determination of the expression of mRNA (RT-PCR) and protein (Western-blot) of mu-receptor and beta-arrestin 2.
Transcription (expression) of beta-arrestin 2
1) Confidence 0.59 Published 2009 Journal Zhonghua Yi Xue Za Zhi Section Body Doc Link 19615194 Disease Relevance 0 Pain Relevance 0
However, after chronic morphine treatment, beta-arrestin 2 mRNA level decreased by 40% in periaqueductal gray and increased by 25% in cerebral cortex, in strong contrast to the unchanged beta-arrestin 1 mRNA level in these two brain regions.
Transcription (level) of beta-arrestin 2 in brain associated with cerebral cortex, central grey and morphine
2) Confidence 0.47 Published 2003 Journal Neuroscience Section Abstract Doc Link 12614678 Disease Relevance 0.20 Pain Relevance 1.30
In the current study, we investigated the potential regulatory effects of morphine administration on beta-arrestin 1 and beta-arrestin 2 mRNA levels in different brain regions in rat using in situ hybridization method.
Transcription (levels) of beta-arrestin 2 in brain associated with morphine
3) Confidence 0.47 Published 2003 Journal Neuroscience Section Abstract Doc Link 12614678 Disease Relevance 0 Pain Relevance 0.80
The acute morphine administration had no significant effect on beta-arrestin 1 or beta-arrestin 2 mRNA level in periaqueductal gray and cerebral cortex.
Transcription (level) of beta-arrestin 2 in cerebral cortex associated with cerebral cortex, central grey and morphine
4) Confidence 0.47 Published 2003 Journal Neuroscience Section Abstract Doc Link 12614678 Disease Relevance 0.19 Pain Relevance 1.28
Our results showed that the acute morphine administration (10 mg/kg) resulted in approximately 30% reduction in both beta-arrestin 1 and beta-arrestin 2 mRNA levels in hippocampus while the chronic morphine treatment (10 mg/kg, b.i.d., for 9 days) caused no significant change in level of either beta-arrestin mRNA.
Transcription (levels) of beta-arrestin 2 in hippocampus associated with hippocampus and morphine
5) Confidence 0.47 Published 2003 Journal Neuroscience Section Abstract Doc Link 12614678 Disease Relevance 0.11 Pain Relevance 0.99

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox